Mechanisms of Action of Dorsal Root Ganglion Stimulation for Chronic Pain
背根神经节刺激治疗慢性疼痛的作用机制
基本信息
- 批准号:10199761
- 负责人:
- 金额:$ 3.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAfferent NeuronsAlternative TherapiesAmericanAnalgesicsAnatomic ModelsAnatomyAutomobile DrivingBiological MarkersCellsCessation of lifeClinicalClinical DataClinical Decision Support SystemsComputer ModelsDataDiseaseDorsalElectrodesElectromyographyElectrophysiology (science)EnsureFDA approvedGangliaGoalsHealth Care CostsHistologicHistologyHumanImplantIndividualIntractable PainKnowledgeLeadLocationMagnetic Resonance ImagingMeasurementMeasuresMedicalMichiganModelingMuscleNeuronsOpioidOrthopedic SurgeryOutcomeOverdosePainPain MeasurementPaintParesthesiaPatient-Focused OutcomesPatientsPharmaceutical PreparationsPharmacologic SubstancePhysiologic pulsePhysiologicalPositioning AttributePostoperative PeriodPrevalenceProceduresPublic HealthRefractoryScanningSignal TransductionSocietiesSourceSpinal CordSpinal GangliaStimulusSubcellular AnatomySystemTechnologyTestingTherapeuticUnited StatesVariantVisualWidthX-Ray Computed Tomographyanalogbasebody mapchronic painclinical careclinical implementationclinical painconventional therapydesignexperimental studyfirst-in-humanhuman dataimplementation outcomesimprovedinsightinterpatient variabilityneurophysiologynew technologynovelopioid epidemicpain inhibitionpain reliefpredictive modelingrelating to nervous systemresponsetherapy outcometreatment optimization
项目摘要
Project Summary
The goal of this study is to elucidate the mechanisms of action of dorsal root ganglion stimulation
(DRGS) for chronic pain. Chronic pain affects approximately 100 million Americans, and accounts for more
than 600 billion dollars in healthcare costs each year. DRGS is an FDA-approved neurostimulation therapy for
chronic pain that is refractory to conventional medical management. Although some patients receive sufficient
pain relief in response to DRGS, clinical outcomes are often inconsistent. This variation in pain relief across
patients may be due to poor understanding of the physiological mechanisms governing stimulation-induced
pain relief. Therefore, we seek to uncover these mechanisms to ultimately optimize DRGS and improve clinical
outcomes. This study is driven by previous computer modeling results from our lab showing that within
stimulation parameter ranges used clinically, DRGS is likely driving the activity of large myelinated sensory
neurons. In this proposed study, we will further investigate these mechanisms using computational models to
determine sources of interpatient variability in DRGS outcomes. Furthermore, we will validate these models
using clinical electrophysiological data, and inform the cellular anatomy of our models using histological data.
We hypothesize that electrode location will be the largest source of variability in DRGS outcomes, and that
positive DRGS outcomes will predict predominant activation of large myelinated sensory neurons. This project
aims to characterize the mechanisms of action of DRGS to improve the implementation and outcomes of the
therapy, and the models resulting from this project could be used to systematically design and test novel
stimulation technologies (e.g. electrode and waveform design).
项目总结
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dorsal Root Ganglion Stimulation for Chronic Pain: Hypothesized Mechanisms of Action.
- DOI:10.1016/j.jpain.2021.07.008
- 发表时间:2022-03
- 期刊:
- 影响因子:0
- 作者:Graham RD;Sankarasubramanian V;Lempka SF
- 通讯作者:Lempka SF
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Dwight Graham其他文献
Robert Dwight Graham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
How Spinal Afferent Neurons Control Appetite and Thirst
脊髓传入神经元如何控制食欲和口渴
- 批准号:
DP220100070 - 财政年份:2023
- 资助金额:
$ 3.12万 - 项目类别:
Discovery Projects
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
- 批准号:
23K05594 - 财政年份:2023
- 资助金额:
$ 3.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Neurobiology of Intrinsic Primary Afferent Neurons
内在初级传入神经元的神经生物学
- 批准号:
10477437 - 财政年份:2021
- 资助金额:
$ 3.12万 - 项目类别:
GPR35 on Vagal Afferent Neurons as a Peripheral Drug Target for Treating Diet-Induced Obesity
迷走神经传入神经元上的 GPR35 作为治疗饮食引起的肥胖的外周药物靶点
- 批准号:
10315571 - 财政年份:2021
- 资助金额:
$ 3.12万 - 项目类别:
Neurobiology of Intrinsic Primary Afferent Neurons
内在初级传入神经元的神经生物学
- 批准号:
10680037 - 财政年份:2021
- 资助金额:
$ 3.12万 - 项目类别:
Neurobiology of Intrinsic Primary Afferent Neurons
内在初级传入神经元的神经生物学
- 批准号:
10654779 - 财政年份:2021
- 资助金额:
$ 3.12万 - 项目类别:
Neurobiology of Intrinsic Primary Afferent Neurons
内在初级传入神经元的神经生物学
- 批准号:
10275133 - 财政年份:2021
- 资助金额:
$ 3.12万 - 项目类别:
GPR35 on Vagal Afferent Neurons as a Peripheral Drug Target for Treating Diet-Induced Obesity
迷走神经传入神经元上的 GPR35 作为治疗饮食引起的肥胖的外周药物靶点
- 批准号:
10470747 - 财政年份:2021
- 资助金额:
$ 3.12万 - 项目类别:
Roles of mechanosensory ion channels in myenteric intrinsic primary afferent neurons
机械感觉离子通道在肌间固有初级传入神经元中的作用
- 批准号:
RGPIN-2014-05517 - 财政年份:2018
- 资助金额:
$ 3.12万 - 项目类别:
Discovery Grants Program - Individual
Roles of mechanosensory ion channels in myenteric intrinsic primary afferent neurons
机械感觉离子通道在肌间固有初级传入神经元中的作用
- 批准号:
RGPIN-2014-05517 - 财政年份:2017
- 资助金额:
$ 3.12万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




